FPFeng-Lian Peng

Feng-Lian Peng

*This is an algorithmically generated author record based on publicly available information.

Feng-Lian Peng has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Association Between Whole Blood Iron and Nonalcoholic Fatty Liver Disease in Elderly: A Case–Control Study

    by Zhe-Ying Jiang, Wei-Jia Meng, Ying Wang, Hua-Qin Su, Bi-Xiu Mao, Cai-Li Wang, Feng-Lian Peng, Cui-Ping Li, Lian-Ping He

    Our objective is to investigate the correlation between levels of whole blood iron and the prevalence of NAFLD among elderly populations in the community. This investigation is designed as a case–control study, concentrating on community members aged 60 years and older who underwent physical assessments and had their whole blood iron levels tested at local health service centers from April to September 2021. In total, 786 participants qualified for inclusion in the study. Individuals diagnosed with fatty liver were organized into the NAFLD group (393 cases), while the control group (393 cases) consisted of healthy individuals who participated in physical evaluations during the same timeframe. Whole blood iron levels and other pertinent biochemical markers were assessed for both groups, alongside the collection of general demographic data. The results indicated that the whole blood iron concentration in the fatty liver cohort [(483.42 ± 45.59) mg/L] was significantly elevated compared to the control group [(470.16 ± 47.76) mg/L]. Moreover, levels of whole blood iron, whole blood zinc, whole blood magnesium, and serum low-density lipoprotein cholesterol were all significantly greater in the fatty liver group than in the control group. The multivariate logistic regression analysis demonstrated that, after adjustments for confounding variables such as age and sex, the odds ratio (OR) (95% confidence interval [CI]) for the occurrence of fatty liver in the lowest whole blood iron quartile (Q1) relative to the highest quartile (Q4) was 0.44 (95% CI: 0.25, 0.76). This research demonstrates a strong link between whole blood iron levels and the development of fatty liver within this community. Tracking whole blood iron concentrations could be crucial for the early detection and intervention of fatty liver. As this is a case–control study, the causal relationship between whole blood iron and NAFLD cannot be established.


  • Relationship Between Whole Blood Iron Levels and Lipid Profile Parameters in the General Population: Findings from Routine Physical Examination Report

    by Rou-Jun Pan, Zhi Luo, Yu-Shun You, Jun-Dong Wang, Ya-Qi Chen, Rong-Rong Zhou, Shu-Zi-Qi Chen, Lin-Min Wang, Jun-Xiang Zhao, Hua-Qin Su, et al.

    Dyslipidemia is related to the occurrence and development of many diseases and is a common problem among the general population. A significant link has been identified between dyslipidemia and ferroptosis. Lipid profile parameters are important indicators of dyslipidemia. Iron is the main cause of ferroptosis. However, the relationship between blood lipid parameters and whole blood iron levels has remained unclear. Based on a community population, the study aimed to explore the relationship between whole blood iron levels and blood lipids in Taizhou, China. The blood samples were collected from 1917 community residents, and levels of total cholesterol, triglyceride, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and whole blood iron were measured. Pearson correlation was used to analyze the correlation between whole blood iron levels and lipids profile parameters. The results of the study showed that for both men and women, whole blood iron concentration was positively correlated with total cholesterol, triglycerides, and low-density lipoprotein cholesterol (P < 0.001), but not with high-density lipoprotein cholesterol (P = 0.618, P = 0.083). The positive correlation between whole blood iron and triglycerides was the most significant (P < 0.001, r = 0.138). The above trends were more pronounced among men than among women. Therefore, the study suggested that regulating whole blood iron levels of populations in Taizhou, China, may be a potential strategy for regulating triglycerides, total cholesterol, and low-density lipoprotein. The potential for controlling triglycerides by regulating whole blood iron is more apparent. The result of the study has some implications for the prevention and diagnosis of dyslipidemia among medical staff and residents, especially male residents.


  • Open Access

    NDUFA4L2 expression predicts poor prognosis in clear cell renal cell carcinoma patients

    by Lei Liu, Gongbin Lan, Longkai Peng, Xubiao Xie, Fenghua Peng, Shaojie Yu, Yu Wang, Xiaotian Tang

    Background: NDUFA4L2 is overexpressed in VHL-deficient cell lines and neuroblastoma. The clinical significance of NDUFA4L2 in clear cell renal cell carcinoma (ccRCC) has not been well studied. Therefore, we evaluated the prognostic value of NDUFA4L2 in ccRCC patients. Methods: In our study, NDUFA4L2 expression in 86 cases of ccRCC and adjacent normal tissues was monitored by immunohistochemistry, semi-quantitative RT-PCR, and Western blot analyses. The relationship between NDUFA4L2 expression and the clinical features of ccRCC was assessed. Results: The results showed that NDUFA4L2 protein expression was found to be higher in ccRCC tissues 81.4% (70/86) than in normal tissues 26.7% (23/86) (p = 0.021). The average level of NDUFA4L2 mRNA expression was found to be 122.23 ± 6.018 and 21.34 ± 1.036 in ccRCC tissue and adjacent normal tissue (p < 0.001). NDUFA4L2 expression levels were correlated with some clinical features of ccRCC. Multivariate analysis showed NDUFA4L2 expression was an independent prognostic factor for ccRCC patients. Conclusions: Our study has provided the significant clinical relevance of NDUFA4L2 in ccRCC and suggested that ccRCC patients with NDUFA4L2 overexpression may be suitable as a potential therapeutic target for ccRCC patients.